R for: | ||||
---|---|---|---|---|
Area of 18F-FET uptake | Cho | Cr | tNAA | Cho/tNAA |
Maximum | 0.475 | −0.064 | −0.557* | 0.945† |
Strong | 0.492 | 0.464 | −0.404 | 0.811† |
Moderate | 0.164 | 0.471 | −0.482 | 0.531* |
Low | 0.072 | 0.626* | −0.089 | 0.095 |
CNB | −0.134 | −0.290 | 0.384 | −0.329 |
All tumor areas‡ | 0.501† | −0.022 | −0.880† | 0.891† |
Tumors of following WHO grade§ (no. of subjects): | ||||
II (4) | 0.535* | −0.126 | −0.871† | 0.849† |
III (6) | 0.406* | 0.007 | −0.845† | 0.851† |
IV (5) | 0.705† | 0.036 | −0.913† | 0.947† |
↵* P < 0.05.
↵† P < 0.001.
↵‡ Correlations for combination of all 4 areas in lesions (maximum to low 18F-FET uptake).
↵§ Correlations for all tumor areas in subgroups of patients with WHO grade II, III, and IV gliomas. Patient with gliomatosis cerebri was included in group of patients with glioma of WHO grade III.